Moving Towards A Total Lifecycle Regulatory Approach For AI Devices

Proportionately regulating highly adaptive AI as a medical device can be done with predetermined change control plans. The US, UK and Canada are advancing the concept, as Ropes & Gray and the US FDA explained.